| Product details |
Supply Impact Dates |
Further Details |
NAROPIN 0.2% ropivacaine hydrochloride 40mg/20mL injection ampoule AUST R: 52405Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
22 Jul 2025
to
12 Jan 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
An alternative brand is available.
|
NAROPIN 0.75% ropivacaine hydrochloride 150mg/20mL injection ampoule AUST R: 52399Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
12 Sep 2025
to
15 Dec 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
|
NAROPIN 0.75% ropivacaine hydrochloride 75mg/10mL injection ampoule AUST R: 52400Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
12 Sep 2025
to
14 Jan 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
|
ROPIBAM 0.2% Ropivacaine hydrochloride 400mg/200mL solution for injection bag AUST R: 186571Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
11 Nov 2024
to
31 Dec 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule AUST R: 186566Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
19 Sep 2025
to
30 Nov 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
An alternative brand is available.
|
ROPIBAM 0.75% Ropivacaine hydrochloride 150mg/20mL solution for injection ampoule AUST R: 186569Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
24 Oct 2025
to
30 Nov 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Sponsor is working to expedite the next shipment.
|
ROPIBAM 1% Ropivacaine hydrochloride 200mg/20mL solution for injection ampoule AUST R: 186568Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
24 Oct 2025
to
28 Feb 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Sponsor is working to expedite the next shipment.
|
ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/20 mL solution for injection ampoule AUST R: 195809Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Fresenius Kabi Australia Pty Ltd
Phone:
0293915555
|
From
11 Sep 2025
to
12 Dec 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
Sponsor is working to expedite the next shipment.
Alternative presentations are available.
|
NAROPIN 1% ropivacaine hydrochloride 100mg/10mL injection ampoule AUST R: 52398Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
29 Sep 2025
to
20 Oct 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
ROPIVACAINE KABI ropivacaine hydrochloride 100 mg/10 mL solution for injection ampoule AUST R: 195808Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Fresenius Kabi Australia Pty Ltd
Phone:
0293915555
|
From
06 Sep 2025
to
19 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|
ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule AUST R: 195807Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Fresenius Kabi Australia Pty Ltd
Phone:
02 9391 5555
|
From
16 Jul 2025
to
15 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|
ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule AUST R: 195804Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Fresenius Kabi Australia Pty Ltd
Phone:
02 9391 5555
|
From
21 Jul 2025
to
15 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|
NAROPIN 0.2% ropivacaine hydrochloride 200mg/100mL injection bag AUST R: 52396Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
30 Jun 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag AUST R: 52395Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
NAROPIN 0.2% WITH FENTANYL 200 microgram/100mL ropivacaine hydrochloride 2mg/mL and fentanyl 2 microgram/mL (as citrate) 100mL injection bag AUST R: 72874Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
20 Mar 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/100mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 100ml injection bag AUST R: 72876Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 2 microgram/mL (as citrate) 200mL injection bag AUST R: 72873Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300
|
Deletion from market:
01 May 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 800 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 200mL injection bag AUST R: 72875Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|